Nuvectis Pharma, Inc.
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
NVCT | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1 BRIDGE PLAZA, SUITE 275, 7024 FORT LEE
- Website:
- https://nuvectis.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company that focuses on developing innovative precision medicines to treat serious oncological conditions with unmet medical needs. The company's pipeline features novel targeted therapeutics, including its lead programs NXP800 and NXP900. NXP900 is an oral small molecule inhibitor of the SRC Family of Kinases (SFK), designed for cancer treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Nuvectis Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nuvectis Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nuvectis Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
